A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy

Author： Huang Xiaojun   Wang Fengrong   Chen Yuhong   Liu Ting   Wang Jianxiang   Hu Jianda   Jie Jin   Chen Fangping   Wang Shujie   Shen Zhixiang   Yu Li   Yu Kang   Liang Yingmin  

Publisher： Future Medicine

ISSN： 1746-0913

Source： Future Microbiology, Vol.7, Iss.2, 2012-02, pp. : 201-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tailored treatment of invasive fungal infections

By Maertens Johan   Bryan Jenny  

Future Microbiology, Vol. 3, Iss. 2, 2008-04 ,pp. : 129-132

Future Medicine

Access to resources Recommend Favorite

Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections

By Maschmeyer Georg   Haas Antje  

Future Microbiology, Vol. 1, Iss. 4, 2006-12 ,pp. : 365-385

Future Medicine

Access to resources Recommend Favorite

Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections

By Guinea Jesúús   Bouza Emilio  

Future Microbiology, Vol. 3, Iss. 6, 2008-12 ,pp. : 603-615

Future Medicine

Access to resources Recommend Favorite

Meeting the challenge of invasive fungal infections: part 1

By Maertens Johan   Lyon Sue  

Future Microbiology, Vol. 8, Iss. 9, 2013-09 ,pp. : 1063-1065

Future Medicine

Access to resources Recommend Favorite

Meeting the challenge of invasive fungal infections: part 2

By Maertens Johan   Lyon Sue  

Future Microbiology, Vol. 8, Iss. 10, 2013-10 ,pp. : 1245-1247

Future Medicine

Access to resources Recommend Favorite